Back to MW Marshall Wace, LLP
PTGX
Showing 7 of 21 quarters
Position history for MWMarshall Wace, LLP's holdings in Protagonist Therapeutics, Inc.
Yes. Marshall Wace holds 109,017 shares of PTGX, worth $13.4M, as of its Q2 2026 13F filing. It reduced the position by 519,058 shares (-82.6%) from Q1 2026. Marshall Wace has held PTGX since Q3 2025, across 4 quarterly 13F filings.
Current Value
$13.4M
Current Shares
109,017
Total Value Change
-$828,482
Total Shares Change
-206,356
Quarter-by-Quarter History